European Healthtech startup funding raised during Q1 2023.
In Q1 2023, 175 European Healthtech companies raised a combined €1.6B across 177 funding rounds, down 38.9% versus Q1 2022. UK led by capital raised, and Sofinnova Partners was the most active investor. Data as of 23 Aug 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Evotec | Debt | Feb 2023 | €150M |
| Amolyt Pharma | Series C | Jan 2023 | €129M |
| Hemab Therapeutics | Series B | Feb 2023 | €127M |
| Noema Pharma | Series B |
17 exits · €170M disclosed.
| Verogen | Acquisition | Jan 2023 | €140M |
| Diamond Whites | Acquisition | Feb 2023 | €30M |
| Mar 2023 |
| €105M |
| SoniVie | Series C | Jan 2023 | €56M |
| Grey Wolf Therapeutics | Series B | Jan 2023 | €45M |
| Medwing | Series C | Mar 2023 | €44M |
| Peppy | Series B | Jan 2023 | €42M |
| Lunaphore Technologies | Series D+ | Mar 2023 | €40M |
| Evosep | Other | Jan 2023 | €37M |
| Perspectum | Series C | Jan 2023 | €34M |
| Owkin | Grant | Mar 2023 | €33M |
| Xeltis | Series D+ | Feb 2023 | €32M |
| Prokarium | Other | Feb 2023 | €28M |
| ExeVir Bio | Debt | Jan 2023 | €25M |
